When to treat patients with relapsed follicular lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

When to treat patients with relapsed follicular lymphoma

Published:2017-02-15 Issue:3 Volume:10 Page:187-191
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Cheah Chan Yoon¹²,Seymour John F³⁴

Affiliation:

1. Department of Haematology, Sir Charles Gairdner Hospital and Pathwest Laboratory Medicine, Nedlands, WA, Australia

2. Medical School, University of Western Australia, Crawley, WA, Australia

3. Department of Haematology, Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, Parkville, VIC, Australia

4. Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2017.1291339

Reference51 articles.

1. Follicular lymphoma: prognostic factors for response and survival.

2. Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center.

3. A population-based study of prognosis in advanced stage follicular lymphoma managed by watch and wait

4. Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry Study

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparison of the prognostic performance of the Lugano 2014 and RECIL 2017 response criteria in patients with NHL from the phase III GOYA and GALLIUM trials;eJHaem;2023-10-09

2. Safety and efficacy of atezolizumab with obinutuzumab and bendamustine in previously untreated follicular lymphoma;Blood Advances;2022-10-19

3. Routine imaging for disease surveillance in follicular lymphoma—To comfort the patients or their doctors?;Cancer;2021-06-22

4. Chimeric Antigen Receptor (CAR) T Cell Therapy for Cancer. Challenges and Opportunities: An Overview;Methods in Molecular Biology;2020-08-20

5. Characteristics and outcomes of patients with relapsed follicular lymphoma following retreatment with second-line rituximab-containing chemotherapy;Leukemia & Lymphoma;2020-06-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3